Novo Nordisk, the manufacturer of Wegovy, responded strongly to the initial launch of Hims & Hers compounded semaglutide pill, releasing a company statement describing the product as an unlawful mass compounding, signaling potential legal action
pubmed.ncbi.nlm.nih.gov/11154626/ Sindhusake D, Golding M, Wigney D, et al
Likewise, the neuroprotective effect of semaglutide involves modulation of apoptotic signaling ( GLP-1R agonists may also exert their neuroprotective action increasing level and activity of brain-derived neurotrophic factor, regulating calcium homeostasis, promoting glycolysis, and reducing vascular damage (Wang et al., 2013)
GIP (Glucose-Dependent Insulinotropic Polypeptide) GIP is the second gut hormone targeted by Mounjaros dual mechanism